This study aimed to explore reliable biological tools to optimize pathogenic classification of variants, thereby improving precision diagnosis of <i>GABRA1</i>-associated encephalopathies and epilepsy.<h4>Methods</h4>The dataset of disease-associated and control <i>GABRA1</i> missense variants was curated. This evidence concerns the gene GABRA1 and epilepsy.